Johns Hopkins is the leading pancreatic cancer research center in the world.

The award-winning team at Johns Hopkins University includes internationally recognized experts in pancreatic cancer research and in the care of pancreatic cancer patients. They have taken a deeply collaborative approach to pancreatic cancer research and with expertise in basic, translational, and clinical research, the team has made major discoveries that have provided unique insight into the fundamental nature of pancreatic cancer.

The team’s efforts have driven improvements in patient care through advances in the understanding of inherited pancreatic cancer, the development of screening programs to detect cancer early, and the use of personalized treatments. Click here to learn more about pancreatic cancer research at Johns Hopkins.

Pancreatic Cancer Research Milestones:

  • The discovery of ATMBRCA2, and PALB2, the most common genes responsible for pancreatic cancer that runs in families.
  • The first complete characterization of the changes in DNA that drive pancreatic cancer.
  • The development of blood tests that can detect pancreatic cancer early.
  • The development of next-generation targeted anticancer agents.

What We Hope To Achieve

We hope that by supporting cutting-edge research at Johns Hopkins, Art Creates Cures will transform the diagnosis and treatment of pancreatic cancer, and in so doing provide hope to patients and their families. We aim to fundamentally impact the care of patients by developing a scientific basis for the genetic counseling of people at high-risk of pancreatic cancer, innovative early detection tests to identify patients before their cancer has spread, and personalized treatments based on the specific genetics and biology of a patient’s cancer.